EURE_CART header image
EURE_CART header image
EURE_CART header image

WP9 Ethics Requirements

This work package sets out the 'ethics requirements' related to studies with animal and human that the project must comply with.

Objective of WP9

  • To ensure compliance with the 'ethics requirements' set out in this work package.

  • These ethic requirements are included as deliverables in this work package

    Deliverable 9.1

    Approval for the clinical study must be obtained from the Ethical Committees of the Clinical Centers.

    Deliverable 9.2

    The manufacturing licence for the production of CAR T-cells will be provided to the European Commission.

    Deliverable 9.3, 9.4, 9.8

    All data collection and processing will be carried according to EU and national legislation, under the control of the competent Institutional Data Protection Officer and/or the National Data Protection Authority. Moreover, all the decision and reports of the Data and Safety Monitoring Boards (DSMB) related to the clinical study will be provided to the EC.

    Deliverable 9.5-9.7

    Authorizations for in vivo preclinical studies in mice must be obtained from the involved Institutions.

Newsletter Subscription

Please fill in the information of your subscription.


You have already subscribed to Newsletter Recipients and wish to update or terminate your subscription? Click here!

News Section

With the project coming to an end in June 2021, EURE-CART publishes its... Read more